In partnership with
December 10, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s edition follows Ohio’s move to criminalize cross-border cannabis shopping, tracks how Congress’s hemp THC limits and Medicare’s CBD experiment are pulling federal policy in different directions, and watches courts and local governments reshape taxes, labor rules, and land use around the industry. We do the politics and analysis here, and all of it rides on the reporters and editors who sit through hearings, chase documents, and keep filing stories that give us something solid to decode.
Today’s edition is supported by Fisher Investments and You.com. If you want your work in front of the same decision-makers, reply to this email and we will talk about sponsoring a future edition.
⚠️ Ohio’s border rules and the new hemp template
🏛️ Courts, commissions, and tax fights reshaping programs
🛰️ Capital, technology, and products adjusting in real time
Always read the fine print. Or let us do it for you.
7 Actionable Ways to Achieve a Comfortable Retirement
Your dream retirement isn’t going to fund itself—that’s what your portfolio is for.
When generating income for a comfortable retirement, there are countless options to weigh. Muni bonds, dividends, REITs, Master Limited Partnerships—each comes with risk and oppor-tunity.
The Definitive Guide to Retirement Income from Fisher investments shows you ways you can position your portfolio to help you maintain or improve your lifestyle in retirement.
It also highlights common mistakes, such as tax mistakes, that can make a substantial differ-ence as you plan your well-deserved future.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Ohio lawmakers have enacted legislation that tightens the voter-approved marijuana law and adds new limits on hemp. The measure treats cannabis as lawful only if it comes from an Ohio dispensary or a legal homegrow, which turns trips to Michigan or other neighboring states into potential misdemeanors once products cross the border or leave their original packaging. It creates new transport and packaging offenses that fall directly on consumers as well as licensees. The bill also pares back key civil protections from the voter-approved ballot question, giving judges, landlords, and licensing boards more room to treat cannabis use as a negative factor in custody, housing, and professional discipline cases. On hemp, the legislation tracks the new federal crackdown by banning most intoxicating hemp products outside licensed dispensaries, with a temporary carveout for THC beverages that runs through the end of 2026. Gov. Mike DeWine has pushed for a tougher line on hemp and adult-use access and is expected to sign.
💡 Why It Matters: The legislation offers other states a ready-made template for tightening their own programs and claiming alignment with federal hemp law, and that is where the trouble starts. Isolating state programs sounds like a good local talking point, but it creates criminal exposure for going to the closest dispensary that might be across the border. Border communities already live this tension; local leaders want tax revenue from stores on their side of the line, then push policies that punish residents who follow the same shopping patterns they use for everything else. The hemp piece is even less settled, because the 0.4 milligram limit on total THC per container sits on uncertain ground and will likely face political and legal pressure before it ever fully takes effect. States that lock that number into their own codes may find themselves revisiting it at the same time Congress, FDA, and courts are still arguing over the definition of hemp. The more this template spreads, the more ordinary behavior turns into technical risk, and the real public safety work around potency, youth access, and product integrity falls further into the background.
🧠 THC Group Take: I understand the politics of this, but the policy lacks nuance. It promises control over hemp, a cleaner story about youth access, and a way to look tough on cross-border shopping. In reality, though, it invites enforcement headaches that are hard to defend with a straight face; an officer on the roadside or in a living room still has to decide whether to ask someone where that preroll came from and whether they kept the receipt. As unlikely a scenario as that may be, that anxiety will absolutely change behavior and strike fear in historically vulnerable communities. States expect cannabis licensees to be good neighbors by managing odor, traffic, and loitering, then turn around and treat their own residents as misbehaving if the nearest compliant storefront happens to sit a few miles away in another jurisdiction. On hemp, locking into the 0.4 milligram standard looks more like betting on a number than building a long-term framework, especially when there is a real chance that federal definitions will be revised under pressure from patients, seniors, and even agencies that want to study CBD in serious care settings. A more durable strategy would tighten youth access, potency, and labeling rules at home while leaving room to adapt as federal policy evolves, instead of chasing a moving target and criminalizing the small geography of where people choose to shop. We’ll see how this plays out.
Fast-moving headlines, flagged for what matters.
Federal hemp policy now carries the fingerprints of Project 2025 in live statute. The new law caps hemp products at 0.4 milligrams of total THC per container, bans most chemically converted cannabinoids, and redefines seeds based on the potential THC of the plants they produce. That combination pushes the current intoxicating hemp market toward a hard shutdown date in late 2026 and invites FDA, DEA, and DOJ to treat delta 8 and related compounds as straightforward Schedule 1 conduct. Heritage-aligned policy shops have long argued for pulling cannabis and hemp back under centralized federal control, and this statute reads like their first successful blueprint. State lawmakers now have to decide whether to build clean channels for hemp beverages, seeds, and adult-use cannabis or let federal enforcement pressure collapse them into a single, fragile system that fails all three. (High Times)
Texas regulators are turning their emergency restrictions on hemp THC into a permanent rule structure that locks in a 21-plus floor for all consumable products. The Texas Alcoholic Beverage Commission and Department of State Health Services are coordinating language so bars, liquor stores, smoke shops, and online sellers follow the same ID-check expectations for hemp drinks and gummies that function as a de facto adult-use channel. While that rulemaking runs, the Compassionate Use Program is preparing to expand, with nine tentative new licensees and an updated process that gives physicians and dispensaries more room to respond to patient demand. Gov. Greg Abbott has chosen to regulate hemp youth access rather than follow calls to ban the category outright, which leaves potency, product design, and manufacturing standards buried in agency practice instead of headline legislation. Brands that built their business on Texas hemp sales now operate inside a more formal public safety frame while they wait to see whether the federal crackdown forces a deeper reset. (Marijuana Moment)
A new citizen initiative in Maine aims to wind down the state’s adult-use cannabis market and send commercial sales back into prohibition within a few years. The proposal would repeal licensing for recreational cultivation, manufacturing, and retail while keeping possession of up to 2.5 ounces legal and allowing current adult-use operators to convert into the medical program. It layers new testing and seed-to-sale tracking requirements onto medical cannabis, a set of obligations caregivers have resisted for years in Augusta. Organizers have until mid-2027 to collect more than 67,000 valid signatures from registered voters, which would set up a statewide vote on whether cannabis should return to a medical-only regime. If it qualifies, the campaign will show whether a narrow 2016 win for legalization has hardened into durable support or remains vulnerable once voters see repeal framed as a way to protect kids, neighborhoods, and small-town culture. (Maine Public)
Michigan’s cannabis trade groups are moving quickly to appeal after a Court of Claims judge let the state’s new 24% wholesale tax proceed toward a 2026 start date. The Michigan Cannabis Industry Association and other plaintiffs say the judge misread the 2018 legalization initiative, which set a 10% excise tax “in addition to all other taxes,” and argue the wholesale levy functions as an unauthorized amendment that should have required a three quarters vote. Public statements from MCIA telegraph a long fight, with leaders describing the tax as a late night budget bolt-on that reshapes the framework voters approved without meaningful debate. State lawyers counter that the wholesale tax fits well within MRTMA’s broad language and looks like any other revenue measure that legislatures routinely adopt. Operators now have to build financial models that assume the tax will take effect while they wait to see whether appellate judges treat Michigan’s marijuana law as flexible revenue scaffolding or as a limit on how creative lawmakers can get. (CBS Detroit)
We spent some time on this yesterday, but New York’s Omnium Canna saga has moved into a procedural fog, with OCM asking to withdraw its notice of pleading after months of work on an alleged “rent a license” inversion scheme. Regulators had already ordered a sweeping recall for Omnium-linked brands, laid out a theory of untracked product flowing into the legal market, and sought revocation, debarment, and significant fines before the case started to unravel in public. The agency now says it has withdrawn the action without prejudice and reserved the right to return, while an administrative law judge still has to formalize how that dismissal lands on the record and whether Omnium walks away clean or under a cloud that allows a refiling. For anyone who has sat on the regulatory side of the table, this is the hard part: suspicion, pattern recognition, and “everyone knows what’s going on” do not count unless the file can carry a burden of proof through hearings and potential appeals. New York’s adult-use market still has real potential, yet episodes like this recall and retreat sequence burn trust with retailers, brands, and consumers who need to see a system that can both chase inversion and finish what it starts. (New York Times)
Virginia’s Department of Labor and Industry has issued guidance telling employers to distinguish between cannabis use and on-the-job impairment instead of relying on a positive test result as automatic grounds for discipline. The document confirms that registered medical cannabis patients cannot be punished solely for lawful use of certified products, while preserving carveouts for federal contractors and defense-related roles where national rules still dominate. Employers retain the power to ban use, storage, or intoxication at work and during on-call periods, but the agency pushes companies to base decisions on behavior, safety, and clearly written zero-tolerance policies. The guidance fits into a broader trend in which workplace norms around cannabis shift even when adult-use retail markets lag behind. Companies that ignore the distinction between metabolites and impairment now run a higher risk of stepping outside the lines regulators are quietly drawing around what counts as a fair employment practice. (Marijuana Moment)
Oregon’s cannabis businesses are asking the Ninth Circuit to uphold a ruling that struck down Measure 119, the voter-approved law that tied licensure to labor peace agreements and employer neutrality. Bubble’s Hash and Ascend Dispensary argue that Measure 119 forces them to surrender speech rights and bargaining positions that the National Labor Relations Act protects, and that the state cannot condition a license on neutrality in union organizing. A federal district judge agreed in May, holding that the measure is preempted by the NLRA and oversteps Oregon’s authority even in a federally illegal industry. Gov. Tina Kotek and the OLCC are pushing for reversal, while unions and worker advocates see the appeal as a test of tools they have relied on in blue-state cannabis laws up and down the map. However the panel rules, the opinion will shape how far states can go in writing labor peace into cannabis statutes before they collide with national labor law. My advice? Stop fighting unions if you’re planning future political maneuvers. You’ll want them on your side. (Marijuana Moment)
Sonoma County supervisors are preparing to vote on a Cannabis Program Update that would turn years of incremental fixes and land-use fights into a single, durable framework. The package would classify cannabis as a controlled agricultural crop, adopt a long-running Environmental Impact Report, and adjust zoning so most supply-chain activities in industrial and commercial areas become by-right uses. It also opens more space for on-site consumption and gives cultivators in agricultural zones protections closer to what other farmers enjoy, while consolidating permitting and compliance functions. Opponents in rural neighborhoods point to odor, traffic, and water as reasons to keep tighter caps, while operators describe the update as basic normalization that lets them plan capital investments on more than a one-hearing horizon. The vote will reveal whether Sonoma’s political center now sees cannabis as part of its agricultural base or keeps it in a special category that has to be renegotiated parcel by parcel. (Press Democrat)
Cronos Group just agreed to buy Dutch producer CanAdelaar for roughly 67 million dollars in cash, plus an earn-out tied to future EBITDA, to anchor its European strategy in the Netherlands’ adult-use pilot. CanAdelaar is the largest supplier in the Wietexperiment program, which runs a four year trial of a closed legal supply chain across ten municipalities and functions as Europe’s most advanced adult-use test bed. The target brings about 47 million dollars in revenue and 28 million dollars in EBITDA over the past year, which puts the upfront price at a discount to many North American deals and reflects the value Cronos sees in industrial greenhouse capacity. Closing is expected in early 2026, pending Dutch regulatory approvals, and the acquisition plugs into Cronos’ push to build borderless brands and product formats that can move between Canada, Israel, and Europe with modest local adjustments. The tradeoff for that footprint is deeper exposure to regulators who are still deciding how comfortable they are with foreign control over a program that may evolve into the continent’s first durable adult-use template. (Reuters)
Stiiizy has picked up a dozen former Gold Flora dispensaries in a court-approved $25 million deal, turning a distressed sale into another expansion step in a shrinking California market. The purchase covers leases and licenses for 12 locations that Gold Flora surrendered after a debt-heavy strategy and the collapse of the Parent Company left key assets in workout territory. A rival operator, Sweet Leaf, tried to derail the auction by arguing that post-sale price adjustments and non-transferable licenses should disqualify Stiiizy’s bid, but a Los Angeles judge allowed the transaction to stand. The chain now controls 58 California stores plus a small Michigan footprint, which makes its low-priced vapes and flower even harder for independents to avoid when they plan shelf sets and promotions. Stiiizy’s growing footprint also carries ongoing pesticide and diversion allegations into each new local process, and those concerns will shadow its applications in every city that has to sign off on the next location. (SFGATE)
Neighbors who tried to pull Michigan’s cannabis regulator and a licensed grow into a federal racketeering fight just watched most of their case disappear. A Michigan federal judge dismissed RICO and nuisance claims brought by a couple who said odor from a nearby cultivation site interfered with the use and enjoyment of their property, and the ruling also lets the state regulator and the marijuana company exit the lawsuit entirely. The court was not persuaded that a licensed operation and its overseer fit the “enterprise” and “racketeering activity” boxes that Congress had in mind when it wrote the RICO statute. What remains for the plaintiffs is a narrower path against remaining local actors, without the leverage that comes from treble damages and nuisance theories pointed at regulators and state-legal businesses. For other markets, the opinion is another signal that federal courts are reluctant to turn cannabis odor disputes into organized crime cases, especially when operators are moving inside a state licensing system. (Law360)
CMS is inching toward a world where Medicare Advantage plans can cover certain state-legal CBD products, effectively treating them as real therapeutics for seniors with chronic pain, sleep issues, and anxiety. At the same time, Congress has advanced a hemp restriction that would rewrite the definition of legal hemp so tightly that many full-spectrum CBD products, with trace cannabinoids beyond pure CBD, could fall out of bounds by 2026. Public health commentators are now connecting those dots in print, arguing that one arm of the federal government cannot credibly promote cannabinoid coverage while another moves to criminalize the formulations most patients actually use. The picture that emerges for lawmakers is an unstable posture where Medicare wants to study CBD in real-world care and federal drug policy undercuts the supply chain at the same time. That kind of split may be politically convenient in the short run, but it is hard to imagine it surviving once seniors, plans, and courts all start asking which version of federal cannabis policy they are supposed to believe. (American Council on Science and Health)
When training takes a backseat, your AI programs don't stand a chance.
One of the biggest reasons AI adoption stalls is because teams aren’t properly trained. This AI Training Checklist from You.com highlights common pitfalls and guides you to build a capable, confident team that can make the most out of your AI investment. Set your AI initiatives on the right track.
From the hearing room to the comment section — we’re watching it all.
🥇 Pharos Premium Infused Beverages just swept two national hemp THC beverage competitions, picking up medals across its low-dose sparkling fruit lineup aimed squarely at older adults. In a category still wrestling with youth-access headlines and “weed seltzer” stereotypes, a senior-focused brand cleaning up on awards is a quiet signal about where some of the steadiest demand may live. (StreetInsider)
🌱 Commercial seeds are sliding back into cannabis grow rooms as breeders roll out genomics driven lines that hit yield and potency targets without the overhead of mother rooms and long veg cycles. For growers willing to rewrite SOPs and retrain staff, seeds become both a cost lever and a recovery tool when a room is knocked offline by contamination or equipment failure. (Cannabis Industry Journal)
🚔 Cannabix Technologies’ handheld marijuana breath collection unit just cleared FCC and Canadian emissions testing, which moves the device closer to workplace and forensic deployment. The science of what a single THC breath reading actually proves still lags behind the hardware, and that gap will drive the real fights in courtrooms and HR offices. (GlobeNewswire)
🧾 A BuzzFeed roundup of anonymous cannabis “confessions” leans hard on shock value and secret-shop vibes while skimming past the structural problems that actually shape those stories. The piece still lands as a reminder that low pay, thin training, and chaotic management live inside a patchwork of rules that were never designed for stable front-line careers. (BuzzFeed)